Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1.
Moyle G; DeJesus E; Boffito M; Wong RS; Gibney C; Badel K; MacFarland R; Calandra G; Bridger G; Becker S; Clinical Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of America, 2009, vol. 48, issue 6, p 798, ISSN 15376591. ISBN 15376591.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef